Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hcw Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
HCWB
Nasdaq
8731
https://hcwbiologics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hcw Biologics Inc
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
- Apr 1st, 2024 8:10 pm
Rebecca Byam Bought 122% More Shares In HCW Biologics
- Feb 24th, 2024 12:44 pm
Several Insiders Invested In HCW Biologics Flagging Positive News
- Jan 25th, 2024 10:41 am
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
- Nov 14th, 2023 12:00 pm
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
- Nov 8th, 2023 12:30 pm
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
- Nov 1st, 2023 11:30 am
Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc
- Sep 16th, 2023 3:00 pm
Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc
- Sep 14th, 2023 5:27 pm
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
- Sep 6th, 2023 11:30 am
Insider Stock Buying Reaches US$845k On HCW Biologics
- Aug 18th, 2023 10:03 am
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
- Aug 11th, 2023 11:00 am
The past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitable
- Jul 7th, 2023 10:28 am
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
- Jun 14th, 2023 11:30 am
HCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022)
- May 10th, 2023 10:13 am
HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights
- May 9th, 2023 11:15 am
Scroll